Summary
I work as part of the MS research team carrying out commercial and academic studies. I am also involved in the biology of MS and novel imaging techniques.
Publications
Journals
Cortese R, Carrasco FP, Tur C, et al. , 2023, Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging, Neurology, Vol:100, ISSN:0028-3878, Pages:E308-E323
Forsberg L, Spelman T, Klyve P, et al. , 2023, Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers., Mult Scler J Exp Transl Clin, Vol:9, ISSN:2055-2173
Montgomery SM, Green L, Karoui H, et al. , 2023, To wait, or too late? Modeling the effects of delayed ofatumumab treatment in relapsing-remitting multiple sclerosis., J Med Econ, Vol:26, Pages:139-148
Barritt AW, Das E, Morley N, et al. , 2022, Management approach including pembrolizumab for fingolimod-associated progressive multifocal leukoencephalopathy in a patient with relapsing-remitting multiple sclerosis, Multiple Sclerosis Journal, ISSN:1352-4585
Simpson-Yap S, Pirmani A, Kalincik T, et al. , 2022, Updated Results of the COVID-19 in MS Global Data Sharing Initiative Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity, Neurology-neuroimmunology & Neuroinflammation, Vol:9, ISSN:2332-7812